<DOC>
	<DOCNO>NCT01768299</DOCNO>
	<brief_summary>A double-blind randomized control trial compare shorter interval administration mifepristone misoprostol ( simultaneous administration compare 24hours administration mifepristone receipt first dose misoprostol ) termination pregnancy 13-22 week gestation . The investigator hypothesize shorten interval may achieve comparable efficacy terminate pregnancy , whilst reduce duration procedure turn , duration hospitalization .</brief_summary>
	<brief_title>Medical Abortion With Mifepristone + Misoprostol ( 13 - 22 Weeks )</brief_title>
	<detailed_description />
	<mesh_term>Mifepristone</mesh_term>
	<mesh_term>Misoprostol</mesh_term>
	<criteria>Closed cervical o vaginal bleeding Live fetus time presentation service No contraindication medical abortion study procedure , accord provider Able consent participate study , either read consent document consent document read sign informed consent Willing follow study procedure Known previous transmural uterine incision &gt; 5 parity Signs symptom infection Any contraindication vaginal delivery , include placenta previa Presentation active labor ( defined moderate severe contraction every 10 minute less )</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>abortion</keyword>
	<keyword>medical abortion</keyword>
	<keyword>mifepristone</keyword>
	<keyword>misoprostol</keyword>
</DOC>